Saturday, November 22, 2014 Heshvan 29, 5775
Testicular malignancies affect a younger demographic than prostate tumors
By:
Elyse Glickman, Special Sections Feature
Prostate cancer and PSA scores have gotten a lot of airtime and print for a variety of reasons, ranging from media exposure like pharmaceutical ads to celebrity survivors of the illness. Testicular cancer may not have as much media play at the moment or as many diagnoses (8,000 new diagnoses every year, compared to 200,000 for prostate cancer), but its...
Comment0
Are certain cancers hereditary — or are there other reasons for disease clusters among related generations
By:
Elyse Glickman, Special Sections Feature
With the concept of “pre-existing conditions” making front-page news in the ongoing tug-of-war focused on U.S. health care, it is not surprising that an increasing number of Americans are making more of a concerted effort to track their family health history. Research reveals that regular check-ups and informative websites barely scratch the surface when it comes to family legacies. Indeed,...
Comment0
Does the diagnosis of one lead to an end of the other?
By:
Lauren Kramer, Special Sections Feature
Sexual intimacy is one way couples bond and reaffirm their affection for and their attractiveness to one another. For patients living with a breast cancer diagnosis, those affirmations are more important than ever. But getting intimate can be complicated when your libido is compromised by the very drugs you hope will cure you. Women living with a breast cancer diagnosis...
Comment0
One doctor looks for ‘an explosion’ in the next decade’s battle to bring breast cancer to its knees
By:
Rachel Vigoda, Special Sections Feature
President John F. Kennedy pledged in 1961 to put a man on the moon by the end of the decade. It took less than nine years to accomplish. In 1971, President Richard Nixon promised there would be a cure for cancer in 10 years. It’s been 41 — and researchers are just starting to figure out what’s taking so long...
Comment0
By:
Elyse Glickman, Jewish Exponent Feature
Though common sense dictates that men and wom­en should do everything in their power to think proactive and preventative when it comes to their reproductive health, a recent study conducted by the U.S. Preventative Services Task Force made headlines with a hefty claim that blood tests intended to spot prostate cancer could also have unexpected side effects and that, perhaps,...
Comment0
Advertisement
Advertisement

Advertisement